iTeos Therapeutics Inc. (ITOS)

AI Score

Unlock

7.41

0.26 (3.64%)

At close: Apr 24, 2025, 3:59 PM

7.50

1.21%

Pre-market: Apr 25, 2025, 08:12 AM EDT

iTeos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue	n/a	n/a	35M	n/a	-11.3M	n/a	n/a	12.6M	53.91M	19.49M	41.72M	152.52M	240.5M	104.27M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	309K	303K	233K	224K	198K	n/a	226K	203K	202K	180K	163K	n/a	200K	126K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	34.69M	-303K	-11.54M	-224K	-198K	12.6M	53.68M	19.28M	41.51M	152.34M	240.34M	104.27M	-200K	-126K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-49.33M	-48.8M	-14.17M	-47.23M	-40.15M	-43.28M	-42.62M	-24.93M	17.38M	-15.21M	3.33M	120.81M	213.52M	79.41M	-29.34M	-18.69M	-14.94M	-13.53M	-8.53M	-8.24M	-8.24M	-7.7M	-6M	-6.12M
Interest Income	7.66M	8.01M	7.82M	7.39M	7.84M	8.04M	8.04M	7.85M	n/a	3.24M	1.06M	92K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-36.36M	-43.12M	-5.76M	-36.8M	-28.19M	-33.42M	-33.07M	-14.35M	22.75M	-1.99M	8.44M	119.53M	224.04M	72.41M	-26.46M	-13.53M	-14.9M	-10.69M	-7.25M	-5.25M	-5.34M	-6.89M	-5.7M	-4.4M
Net Income	-43.71M	-45.36M	-7.13M	-38.22M	-30.55M	-32.24M	-34.3M	-15.55M	20.45M	991K	5.63M	69.58M	184.87M	69.64M	-26.46M	-13.53M	-14.9M	-10.68M	-7.2M	-5.25M	-5.38M	-6.92M	-5.75M	-4.4M
Selling & General & Admin	11.81M	12.11M	12.46M	12.7M	12.37M	12.64M	13.44M	11.93M	11.1M	10.76M	11.47M	10.62M	9.6M	8.76M	15.1M	7.05M	5.73M	4.8M	2.39M	2.42M	2.28M	2.7M	2.09M	1.77M
Research & Development	37.52M	36.69M	36.4M	34.23M	27.78M	30.64M	29.19M	25.6M	25.42M	23.93M	26.91M	21.1M	17.39M	16.1M	14.24M	11.64M	9.21M	8.73M	6.14M	5.83M	5.96M	5M	3.9M	4.35M
Other Expenses	n/a	n/a	n/a	2.09M	1.21M	771K	326K	n/a	-1.38M	-698K	-439K	-745K	9.57M	-8.48M	60K	240K	-283K	265K	12K	1.22M	945K	-232K	-535K	756K
Operating Expenses	49.33M	48.8M	48.86M	46.93M	37.24M	42.23M	41.44M	37.52M	35.14M	33.99M	37.94M	30.97M	26.03M	23.37M	26.52M	13.77M	14.62M	10.95M	7.26M	6.47M	6.29M	6.66M	5.16M	5.16M
Interest Expense	n/a	n/a	n/a	n/a	8.18M	n/a	n/a	n/a	n/a	n/a	n/a	2.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	49.33M	48.8M	49.17M	47.23M	37.24M	42.23M	41.44M	37.52M	35.14M	33.99M	37.94M	30.97M	26.03M	23.37M	26.52M	13.77M	14.62M	10.95M	7.26M	6.47M	6.29M	6.66M	5.16M	5.16M
Income Tax Expense	7.36M	2.24M	1.37M	1.41M	2.36M	-1.18M	1.23M	1.2M	2.29M	-2.98M	2.82M	49.95M	39.17M	2.77M	-119K	n/a	1K	-8K	-50K	n/a	32K	29K	58K	n/a
Shares Outstanding (Basic)	40.47M	43.14M	39.7M	35.84M	35.84M	35.78M	35.77M	35.72M	35.61M	37.66M	37.51M	38.14M	35.2M	35.2M	35.12M	34.7M	24.35M	24.26M	31.75M	31.75M	9.91M	9.91M	9.91M	9.91M
Shares Outstanding (Diluted)	40.47M	43.14M	39.7M	35.84M	35.84M	35.78M	35.77M	35.72M	37.88M	37.66M	37.64M	38.14M	37.48M	37.48M	35.12M	35.09M	24.35M	24.35M	31.75M	31.75M	9.91M	9.91M	9.91M	9.91M
EPS (Basic)	-1.08	-1.05	-0.18	-1.07	-0.85	-0.9	-0.96	-0.44	0.57	0.03	0.15	1.82	5.26	1.98	-0.75	-0.39	-0.61	-0.44	-0.23	-0.17	-0.54	-0.7	-0.58	-0.44
EPS (Diluted)	-1.08	-1.05	-0.18	-1.07	-0.85	-0.9	-0.96	-0.44	0.54	0.03	0.15	1.82	4.89	1.86	-0.75	-0.39	-0.61	-0.44	-0.23	-0.17	-0.54	-0.7	-0.58	-0.44
EBITDA	-47.78M	-47.69M	-12.44M	-47.23M	-30.34M	-43.28M	-42.62M	-23.63M	22.63M	-15.21M	8.35M	119.46M	224.5M	72.44M	-26.38M	-13.41M	-14.4M	-10.86M	-7.34M	-5.31M	-5.21M	-6.5M	-5M	-4.45M
EBIT	-48.1M	-47.99M	-12.75M	-45.48M	-37.24M	-42.23M	-41.44M	-23.85M	22.4M	-14.51M	8.15M	121.56M	224.33M	72.24M	-26.52M	-13.77M	-14.62M	-10.95M	-7.26M	-6.47M	-5.36M	-6.66M	-5.16M	-5.16M
Depreciation & Amortization	322K	302K	310K	303K	233K	224K	198K	222K	226K	203K	202K	180K	163K	200K	200K	126K	143K	142K	129K	121K	146K	158K	158K	149K